JP2023518985A5 - - Google Patents

Info

Publication number
JP2023518985A5
JP2023518985A5 JP2022558110A JP2022558110A JP2023518985A5 JP 2023518985 A5 JP2023518985 A5 JP 2023518985A5 JP 2022558110 A JP2022558110 A JP 2022558110A JP 2022558110 A JP2022558110 A JP 2022558110A JP 2023518985 A5 JP2023518985 A5 JP 2023518985A5
Authority
JP
Japan
Prior art keywords
lipid
item
pharmaceutically acceptable
alkyl
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022558110A
Other languages
English (en)
Japanese (ja)
Other versions
JP7746280B2 (ja
JP2023518985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024413 external-priority patent/WO2021195529A2/en
Publication of JP2023518985A publication Critical patent/JP2023518985A/ja
Publication of JP2023518985A5 publication Critical patent/JP2023518985A5/ja
Priority to JP2025154013A priority Critical patent/JP2025181861A/ja
Application granted granted Critical
Publication of JP7746280B2 publication Critical patent/JP7746280B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558110A 2020-03-27 2021-03-26 新規脂質及びそれらのナノ粒子組成物 Active JP7746280B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025154013A JP2025181861A (ja) 2020-03-27 2025-09-17 新規脂質及びそれらのナノ粒子組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063000990P 2020-03-27 2020-03-27
US63/000,990 2020-03-27
PCT/US2021/024413 WO2021195529A2 (en) 2020-03-27 2021-03-26 Novel lipids and nanoparticle compositions thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025154013A Division JP2025181861A (ja) 2020-03-27 2025-09-17 新規脂質及びそれらのナノ粒子組成物

Publications (3)

Publication Number Publication Date
JP2023518985A JP2023518985A (ja) 2023-05-09
JP2023518985A5 true JP2023518985A5 (cg-RX-API-DMAC7.html) 2024-04-04
JP7746280B2 JP7746280B2 (ja) 2025-09-30

Family

ID=77890624

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022558110A Active JP7746280B2 (ja) 2020-03-27 2021-03-26 新規脂質及びそれらのナノ粒子組成物
JP2025154013A Pending JP2025181861A (ja) 2020-03-27 2025-09-17 新規脂質及びそれらのナノ粒子組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025154013A Pending JP2025181861A (ja) 2020-03-27 2025-09-17 新規脂質及びそれらのナノ粒子組成物

Country Status (11)

Country Link
US (3) US12534435B2 (cg-RX-API-DMAC7.html)
EP (1) EP4125821A4 (cg-RX-API-DMAC7.html)
JP (2) JP7746280B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220160647A (cg-RX-API-DMAC7.html)
CN (1) CN115916163A (cg-RX-API-DMAC7.html)
AU (1) AU2021241696B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022019369A2 (cg-RX-API-DMAC7.html)
CA (1) CA3173126A1 (cg-RX-API-DMAC7.html)
IL (1) IL296763B2 (cg-RX-API-DMAC7.html)
MX (1) MX2022011988A (cg-RX-API-DMAC7.html)
WO (1) WO2021195529A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
US12534435B2 (en) * 2020-03-27 2026-01-27 Generation Bio Co. Lipids and nanoparticle compositions thereof
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
CN118251212A (zh) * 2021-09-30 2024-06-25 日油株式会社 用于将核酸递送至淋巴管内皮细胞的脂质纳米颗粒
WO2023121964A1 (en) * 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterials comprising disulfides
JPWO2023190164A1 (cg-RX-API-DMAC7.html) * 2022-03-28 2023-10-05
CA3247022A1 (en) 2022-03-28 2025-07-08 National University Corporation Chiba University METHOD FOR PRODUCING LIPID NANOPARTICLES ENCAPSULATED IN A NUCLEIC ACID, METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO A CELL OR A TARGET CELL
WO2023190175A1 (ja) 2022-03-28 2023-10-05 日油株式会社 末梢血単核細胞へ核酸を送達するための脂質ナノ粒子およびこれを用いて末梢血単核細胞へ核酸を送達する方法
JPWO2023190176A1 (cg-RX-API-DMAC7.html) 2022-03-28 2023-10-05
WO2023230587A2 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
KR20250038709A (ko) 2022-07-15 2025-03-19 니치유 가부시키가이샤 지질 나노입자 및 이의 제조 방법, 핵산-캡슐화 지질 나노입자 및 이의 제조 방법, 및 핵산-캡슐화 지질 나노입자를 사용하여 생체에서 획득 면역을 유도하는 방법
KR20250037535A (ko) 2022-07-15 2025-03-17 니치유 가부시키가이샤 핵산-로딩된 지질 나노입자의 동결건조 조성물
WO2024192528A1 (en) * 2023-03-22 2024-09-26 Nanovation Therapeutics Inc. Ionizable anionic lipids
WO2024203660A1 (ja) 2023-03-29 2024-10-03 国立大学法人東北大学 核酸内封脂質ナノ粒子の製造方法
CN116082184B (zh) * 2023-04-12 2023-06-30 山东大学 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025043146A2 (en) * 2023-08-24 2025-02-27 Molecular Axiom Inc. Lipid nanoparticle compositions and methods of using same
CN121909024A (zh) 2023-09-22 2026-04-21 国立大学法人东北大学 包封有核酸的配体修饰脂质纳米颗粒的制造方法
US20260234104A1 (en) * 2023-12-15 2026-08-13 Xiamen Sinopeg Biotech Co., Ltd. Degradable cationic lipid containing a disulfide bond and applications thereof
WO2025150516A1 (ja) 2024-01-12 2025-07-17 日油株式会社 核酸内封脂質ナノ粒子を含む凍結組成物
CN117964577B (zh) * 2024-03-29 2024-06-21 天津全和诚生物技术有限公司 阳离子脂质化合物、其制备方法、包含其的组合物及应用
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026070952A1 (ja) * 2024-09-27 2026-04-02 日油株式会社 ジスルフィド結合を有する化合物およびその製造方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
CA2289702C (en) 1997-05-14 2008-02-19 Inex Pharmaceuticals Corp. High efficiency encapsulation of charged therapeutic agents in lipid vesicles
US6320017B1 (en) 1997-12-23 2001-11-20 Inex Pharmaceuticals Corp. Polyamide oligomers
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
WO2002087541A1 (en) 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CN1882693B (zh) 2003-09-15 2012-08-15 普洛体维生物治疗公司 聚乙二醇修饰的脂质化合物及其应用
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
WO2008103276A2 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
EP3100718B1 (en) 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP2310440A4 (en) 2008-07-10 2013-06-05 Serina Therapeutics Inc POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS
EP3391877A1 (en) 2010-04-08 2018-10-24 The Trustees of Princeton University Preparation of lipid nanoparticles
WO2011139911A2 (en) 2010-04-29 2011-11-10 Isis Pharmaceuticals, Inc. Lipid formulated single stranded rna
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
US20120225129A1 (en) 2010-08-20 2012-09-06 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
WO2012046265A1 (ja) * 2010-10-05 2012-04-12 トヨタ自動車株式会社 推定装置および推定方法
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
CA2853689C (en) 2011-11-04 2020-06-30 Nitto Denko Corporation Method of producing lipid nanoparticles for drug delivery
WO2013073480A1 (ja) * 2011-11-18 2013-05-23 日油株式会社 細胞内動態を改善したカチオン性脂質
US9035039B2 (en) * 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
TWI595885B (zh) 2012-05-02 2017-08-21 喜納製藥公司 包含四galnac之新穎結合物及傳送寡核苷酸之方法
US10426737B2 (en) 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2017084987A1 (en) 2015-11-16 2017-05-26 F. Hoffmann-La Roche Ag GalNAc CLUSTER PHOSPHORAMIDITE
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
US12678515B2 (en) 2015-12-30 2026-07-14 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
IL261524B2 (en) 2016-03-03 2023-10-01 Univ Massachusetts End-capped linear double-stranded DNA for non-viral gene transfer
JP2019151589A (ja) * 2018-03-02 2019-09-12 国立大学法人北海道大学 脂質ナノ粒子
CA3094057C (en) * 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS
JP7075256B2 (ja) * 2018-03-28 2022-05-25 三菱重工業株式会社 配管の余寿命評価方法
CN114929205B (zh) 2019-09-06 2024-09-03 世代生物公司 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法
US12534435B2 (en) 2020-03-27 2026-01-27 Generation Bio Co. Lipids and nanoparticle compositions thereof
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof

Similar Documents

Publication Publication Date Title
JP2023502576A5 (cg-RX-API-DMAC7.html)
JP2022546597A5 (cg-RX-API-DMAC7.html)
JP2024517644A5 (cg-RX-API-DMAC7.html)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
JP2024522692A5 (cg-RX-API-DMAC7.html)
JP2023534043A5 (cg-RX-API-DMAC7.html)
JP2023527747A5 (cg-RX-API-DMAC7.html)
KR20230052895A (ko) 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형
US20240293574A1 (en) Cationic lipids and compositions thereof
WO2021046265A1 (en) Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof
US20240226325A1 (en) Cationic lipids and compositions thereof
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
RU2023129760A (ru) Катионные липиды и их композиции
RU2023135629A (ru) Катионные липиды и их композиции